Skip to main content

Table 1 Protection levels (% of reduction, R) in worm recovery (total counts, females and males), hepatic damage extension (mm2/100 mm2) and number of eggs per gram (EPG) in the tissues in vaccinated BALB/c mice using natural and recombinant FABP (nFh12, rFh15 or rFh15b) formulated with the adjuvant adaptation (ADAD) vaccination system with the natural immunomodulator PAL or the synthetic AA0029. Data presented as the mean ± standard error of the mean. ANOVA F- and P-values, and post-hoc Tukey’s honest significance test P values of significant increases are included

From: Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems

Groups

Total worms

R

Females

R

Males

R

Hepatic lesion

R

EPG in liver

R

EPG intestine

R

 

(mean ± SEM)

(%)

(mean ± SEM)

(%)

(mean ± SEM)

(%)

(mean ± SEM)

(%)

(mean ± SEM)

(%)

(mean ± SEM)

(%)

Experiment 1

Infected

36.3 ± 4.9

19.7 ± 2.9

16.6 ± 2.0

64.1 ± 7.1

17,432 ± 3,586

14,812 ± 3,934

PAL+Qs

23.4 ± 2.5

36

12.4 ± 1.4

37

11.1 ± 1.0

33

74.4 ± 6.4

NR

16,551 ± 2,620

5

17,367 ± 2,277

NR

PAL+Qs+nFh12

6.0 ± 1.7 P < 0.001a

83

3.6 ± 1.0 P < 0.001a

82

2.1 ± 0.8 P < 0.001a

87

9.4 ± 3.0 P < 0.001a

85

3,089 ± 1,001 P = 0.001a

82

1,186 ± 523 P < 0.001a

92

ANOVA

F (2,24) = 23.39 P < 0.001

 

F (2,24) = 18.49 P < 0.001

 

F (2,24) = 30.13 P < 0.001

 

F (2,24) = 39.41 P < 0.001

 

F (2,24) = 10.27 P < 0.001

 

F (3,32) = 16.31 P < 0.001

 

Experiment 2

Infected

49.0 ± 6.1

24.0 ± 7.3

25.0 ± 8.8

61.2 ± 8.3

18,008 ± 2,362

-

18,197 ± 2,079

PAL+Qs

31.6 ± 3.4

35

18.6 ± 2.1

22

13.5 ± 1.2

46

71.0 ± 6.2

NR

17,098 ± 2,706

5

21,700 ± 2,968

NR

PAL+Qs+rFh15

21.8 ± 2.5 P = 0.006a

56

9.0 ± 1.2 P < 0.001a

63

12.8 ± 1.5 P < 0.001a

49

18.7 ± 2.2 P < 0.001a

69

14,247 ± 668

21

12,724 ± 488

30

ANOVA

F (2,24) = 9.04 P < 0.001

 

F (2,24) = 13.80 P < 0.001

 

F (2,24) = 9.93 P < 0.001

 

F (2,24) = 18.37 P < 0.001

     

Experiment 3

Infected

34.5 ± 6.9

18.0 ± 3.6

16.5 ± 3.4

61.8 ± 14.4

9,986 ± 2,360

7,748 ± 1,315

AA0029+Qs

42.5 ± 8.0

NR

20.0 ± 4.4

NR

22.5 ± 3.9

NR

77.0 ± 19.0

NR

13,242 ± 1,597

NR

8,084 ± 775

NR

AA0029+Qs+rFh15

12.5 ± 3.8 P = 0.046a

64

5.5 ± 2.0 P = 0.011a

69

7.0 ± 2.0 P = 0.041a

58

20.6 ± 14.0 P = 0.049a

67

3,872 ± 1,814 P = 0.024a

61

1,800 ± 730 P = 0.001a

77

AA0029+Qs+rFh15b

25.1 ± 7.8

27

10.1 ± 3.2 P = 0.021a

44

15.0 ± 4.8

9

15.2 ± 7.1 P = 0.048a

75

4,692 ± 1,181 P = 0.035a

53

3,098 ± 800 P = 0.001a

60

ANOVA

F (3,32) = 3.09 P = 0.047

 

F (3,32) = 3.75 P = 0.026

 

F (3,32) = 2.97 P = 0.048

 

F (3,32) = 4.05 P = 0.007

 

F (3,32) = 4.25 P = 0.003

 

F (3,32) = 11.61 P < 0.001

 
  1. NR no-reduction: aSignificant differences in comparison with infected controls